Cargando…

Neoadjuvant anti-PD-1 immunotherapy for recurrent glioblastoma

Detalles Bibliográficos
Autores principales: Mitchell, Dana, Dey, Mahua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7451720/
https://www.ncbi.nlm.nih.gov/pubmed/32864354
http://dx.doi.org/10.21037/tcr.2019.05.24
_version_ 1783575036112666624
author Mitchell, Dana
Dey, Mahua
author_facet Mitchell, Dana
Dey, Mahua
author_sort Mitchell, Dana
collection PubMed
description
format Online
Article
Text
id pubmed-7451720
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher AME Publishing Company
record_format MEDLINE/PubMed
spelling pubmed-74517202020-08-27 Neoadjuvant anti-PD-1 immunotherapy for recurrent glioblastoma Mitchell, Dana Dey, Mahua Transl Cancer Res Editorial Commentary AME Publishing Company 2019-12 /pmc/articles/PMC7451720/ /pubmed/32864354 http://dx.doi.org/10.21037/tcr.2019.05.24 Text en 2019 Translational Cancer Research. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0/.
spellingShingle Editorial Commentary
Mitchell, Dana
Dey, Mahua
Neoadjuvant anti-PD-1 immunotherapy for recurrent glioblastoma
title Neoadjuvant anti-PD-1 immunotherapy for recurrent glioblastoma
title_full Neoadjuvant anti-PD-1 immunotherapy for recurrent glioblastoma
title_fullStr Neoadjuvant anti-PD-1 immunotherapy for recurrent glioblastoma
title_full_unstemmed Neoadjuvant anti-PD-1 immunotherapy for recurrent glioblastoma
title_short Neoadjuvant anti-PD-1 immunotherapy for recurrent glioblastoma
title_sort neoadjuvant anti-pd-1 immunotherapy for recurrent glioblastoma
topic Editorial Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7451720/
https://www.ncbi.nlm.nih.gov/pubmed/32864354
http://dx.doi.org/10.21037/tcr.2019.05.24
work_keys_str_mv AT mitchelldana neoadjuvantantipd1immunotherapyforrecurrentglioblastoma
AT deymahua neoadjuvantantipd1immunotherapyforrecurrentglioblastoma